Breast cancer is the most common form of cancer in women in the UK, so any positive developments in its diagnosis and treatment are to be welcomed.
In the past two weeks, The Times has reported on two developments in diagnosing and tackling breast cancer which could lead to a reduction in the number of women suffering from this widespread disease.
The National Institute for Health and Clinical Excellence has, apparently, just agreed that the NHS can use two new drugs, Palbociclib and Ribociclib, in the fight against breast cancer. The drugs are believed to halt the growth of tumours for up to ten months and possibly reduce the need for chemotherapy. It is estimated that approximately 8,000 women per year could benefit from these drugs.
In another development, it has been proposed that if more women were tested for the BRCA genes associated with some breast cancer cases, 11,000 cases of breast cancer could be prevented and possibly more than 2,000 lives saved.
Medical Negligence
If you or a loved one have suffered from an unnecessary delay in cancer diagnosis, you should speak with a specialist solicitor regarding a possible claim for compensation.
Contact Glynns Solicitors to discuss your situation with an experienced medical negligence solicitor.
Please call us on 0800 234 3300 (or from a mobile 01275 334030) or complete our Online Enquiry Form.
Share Article With:
|
|
|
|
|
|
